Speaker Faculty

• Haritha Adhikarla, Ph.D., Associate Research Scientist, Albert Ko Laboratory, Yale School of Public Health
• Carl Alving, M.D., Chief, Laboratory of Adjuvant & Antigen Research, U.S. Military HIV Research Program, Walter Reed Army Institute of Research
• Maria Baca-Estrada, Ph.D., Chief, Bacterial & Combination Vaccines, Centre for Biologics Evaluation, Health Canada
• Adam Buckley, MBA, Vice President, VBI Vaccines, Inc.
• Dennis Christensen, Ph.D., Senior Scientist & Head, Vaccine Adjuvant Research Group, Infectious Disease Immunology, Division of Vaccines, Statens Serum Institute
• Simon Delagrave, Ph.D., Senior Director, Head of Virology Research North America, Sanofi Pasteur
• Antu K. Dey, D.Phil., Senior Director, R&D, Vaccine Product Development Center, International AIDS Vaccine Initiative
• Arnaud Didierlaurent, Ph.D., Director, Translational Research & Adjuvant, GlaxoSmithKline Vaccines
• Ali Fattom, Ph.D., Senior Vice President, Vaccine R&D, NanoBio
• Timothy Fouts, Ph.D., Senior Director, Profectus BioSciences
• Laurent M. Humeau, Ph.D., Vice President, Research & Development, Inovio Pharmaceuticals
• Nicholas Jackson, Ph.D., Vice President, Head of Research, Sanofi Pasteur
• Robert Johnson, Ph.D., Director, Office of Regulatory Affairs, Acting Director, Office of Clinical Research Resources, DMID/NIAID/NIH
• Amine Kamen, Ph.D., Professor, Bioengineering, McGill University
• Ming-Chung Kan, Ph.D., CEO, Vaxsia Biomedical
• Takashi K. Kishimoto Ph.D., CSO, Selecta Biosciences
• Harold Kleanthous, Ph.D., Head, Discovery Research, Sanofi Pasteur
• Dennis Klinman, M.D., Ph.D., Senior Investigator, Cancer and Inflammation Program, National Cancer Institute, National Institutes of Health
• Lakshmi Krishnan, Ph.D., Director, Immunobiology & Program Leader, Vaccines and Immunotherapeutics, National Research Council-Human Health Therapeutics, Canada
• Ofer Levy, M.D., Ph.D., Director, Precision Vaccines Program, Boston Children’s Hospital; Associate Professor, Pediatrics, Harvard Medical School
• Shan Lu, M.D., Ph.D., Professor, Medicine, University of Massachusetts Medical School
• Matthias Oberli, Ph.D., Research Associate, Langer Lab, David H. Koch Institute for Integrative Cancer Research, MIT
• Derek O’Hagan, Ph.D., Head, Global Discovery Support & New Technologies, GlaxoSmithKline Vaccines
• Shan Lu, M.D., Ph.D., Professor, Medicine, University of Massachusetts Medical School
• Michael McVoy, Ph.D., Professor, Pediatrics, Virginia Commonwealth University
• Annie Mo, Ph.D., Program Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health
• Yawei Ni, Ph.D., President & CSO, KJ Biosciences
• Nikolai Petrovsky, MBBS, Ph.D., Chairman & Research Director, Vaxine; Professor, Flinders University
• Mark Poznansky, M.D., Ph.D., Associate Professor, Medicine, Harvard Medical School; Director, Vaccine & Immunotherapy Center, Massachusetts General Hospital
• Peter Pushko, Ph.D., President & CSO, Medigen
• Euan Ramsay, Ph.D., Co-Founder & COO, Leadership, Precision NanoSystems, Inc.
• Philip Santangelo, Ph.D., Associate Professor, Biomedical Engineering, Georgia Tech
• Ethan Settembre, Ph.D., Head, Research, Seqirus
• Mario Skiadopoulos, Ph.D., Senior Director, Non-Clinical Development, Emergent BioSolutions
• Ioanna Skountzou, M.D., Ph.D., Associate Professor, Microbiology and Immunology, Emory University School of Medicine
• Karina Smolyar, Formulation Development, Infectious Disease Research Institute
• Gokul Swaminathan, Ph.D., Senior Scientist, Infectious Diseases & Vaccines, Merck Research Laboratories, Merck & Co., Inc.
• Sonia Trépanier, Ph.D., Senior Director, Clinical Studies, Medicago
• Jeffrey Ulmer, Ph.D., Head, Preclinical R&D US, GSK Vaccines
• Dai Wang, Ph.D., Principal Scientist, Infectious Diseases and Vaccines, Merck Research Laboratory
• William Watt, Ph.D., President & CEO, EpiThany, Inc.; University of Washington Tumor Vaccine Group
• Ron Weiss, Ph.D., Professor, Biological Engineering, MIT
• Lee M. Wetzler, M.D., Co-Director for Research, Section of Infectious Diseases, Professor of Medicine and Microbiology, Boston University School of Medicine
• Jens Wrammert, Ph.D., Assistant Professor, Microbiology & Immunology, Emory University School of Medicine
• Jian Yan, Ph.D., Associate Director, Antigen Discovery and Design, Inovio Pharmaceuticals
• Darin Zehrung, Program Advisor, Vaccine & Pharmaceutical Delivery Technologies, PATH